Cover Image

PP 1.36 - 00182 Effect of HIV-1C Transmitted/Founder Viruses 5'LTRand tat Genetic Variation on Viral Reservoir Size and Latency Reversal Potential

Saved in:

Bibliographic Details
Main Authors:	Shreyal Maikoo (Author), Thumbi Ndung'u (Author), Paradise Madlala (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PP 3.14 - 00190 Ex vivo response to latency reversal agents of CD4+ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART
by: K. Gopee, et al.
Published: (2022)

PP 3.7 - 00128 Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes
by: P. Madlala, et al.
Published: (2022)

Suppression of the HIV-1 reservoir with a potent Tat inhibitor
by: S. Valente, et al.
Published: (2015)

Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics
by: LaMont Cannon, et al.
Published: (2024)

Novel SHIVs encoding transmitted/founder envs for latency and cure research
by: K. Bar, et al.
Published: (2017)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
by: A. Bauer, et al.
Published: (2019)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019)

The role of APOBEC 3G/3F in shaping early HIV-1 reservoir landscapes
by: K. Reddy, et al.
Published: (2017)

Multiple NF-κB elements in the LTR of HIV-1 subtype C coordinate with the auto-regulatory circuit of Tat to drive rapid establishment of latency
by: S. Chakraborty, et al.
Published: (2017)

OP 1.7 - 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir
by: M. Pardons, et al.
Published: (2022)

The Knowledge-based Economy: modeled, measured, simulated, Loet Leydesdorff - Book Review DOI: 10.3395/reciis.v1i1.36en
by: Lia Hasenclever, et al.
Published: (2007)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
by: J. Jacobson, et al.
Published: (2017)

Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0-5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa
by: Temitayo Famoroti, et al.
Published: (2018)

Low viral reservoir treated individuals show unusual HIV latency distribution
by: C. Gálvez, et al.
Published: (2019)

PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir
by: J. Howard, et al.
Published: (2022)

Women undergoing reproductive aging show increased reservoir sizes associated with removal of hormonal control of HIV-1 latency by oestrogen
by: C. Dobrowolski, et al.
Published: (2019)

Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
by: Alexander M.L. Hayes
Published: (2020)

The activity of glyoxylase 1 is regulated by glucose-responsive phosphorylation on Tyr136
by: Fabiola Garcia Cortizo, et al.
Published: (2022)

PP 3.4 - 00079 HIV-1 clade C reservoir characteristics in early and chronic treated infection
by: K. Reddy, et al.
Published: (2022)

36 Dose-dependent effects of HDACi on T cell activation and HIV latency reversal
by: X.T. Kuang, et al.
Published: (2016)

HIV-1 Tat and cocaine impact astrocytic energy reservoirs and epigenetic regulation by influencing the LINC01133-hsa-miR-4726-5p-NDUFA9 axis
by: Mayur Doke, et al.
Published: (2022)

The Bath Tatting Book
by: Anonymous

Fine crochet and tatting
by: Spool Cotton Co

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

Molecular characterisation of the inhibitor didehydro-Cortistatin A with the HIV-1 Tat protein
by: S. Mediouni, et al.
Published: (2017)

Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity
by: Jean-Pierre Louboutin, et al.
Published: (2014)

INFECTION PECULIARITIES OF PLACENTA IN WOMEN WITH PREMATURE RUPTURE OF MEMBRANES AT 22 - 36 WEEKS DEPEND ON LATENCY
by: Наталья Николаевна Елизарова, et al.
Published: (2017)

Golden Stars in Tatting and Crochet
by: Riego de la Branchardière, Eléonore

13,6 de mortalidad infantil
Published: (1987)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

The influence of Tat-derived peptide (Tat-LK15) on the uptake of membrane p- glycoproteins substrate (Calcein AM)
by: Myasar Alkotaji, et al.
Published: (2019)

Tat Genlerinin Diş Çürüğüne Etkisi
by: Seçil Özkurt, et al.
Published: (2022)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: Adam Ward, et al.
Published: (2017)

Mannosylated PAMAM G2 dendrimers mediated rate programmed delivery of efavirenz target HIV viral latency at reservoirs
by: Rohini Kharwade, et al.
Published: (2024)

Editorial 36-1
by: Moraima Esteves
Published: (2021)